关键信息
-
基因名
Otoraplin/OTOR
- 应用
-
别名
FDP; MIAL; MIAL1; Fibrocyte-derived protein; Melanoma inhibitory activity-like protein
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q9JIE3
-
表达区间
Ala17~Thr121
-
分子量
15kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Otoraplin (also known as OTOR) is a recombinant protein that has garnered attention in the field of biomedical research due to its potential therapeutic applications. Initially identified for its role in cell differentiation and tissue development, Otoraplin is implicated in various physiological processes, including neural development and immune responses. Recent studies have highlighted its significance in cancer biology, where its altered expression patterns correlate with tumor progression and metastasis. Researchers are keenly investigating the mechanisms by which Otoraplin interacts with cellular pathways, particularly its involvement in signaling cascades that regulate cell growth and apoptosis. Furthermore, the recombinant production of Otoraplin allows for detailed functional studies and the development of potential therapeutic strategies, including its use as a biomarker for disease progression or as a target for novel drug designs. The exploration of Otoraplin's role in pathological conditions opens new avenues for targeted therapies, making it a compelling subject for further investigation in regenerative medicine and oncology. As our understanding of its biological functions deepens, Otoraplin may emerge as a crucial player in developing innovative treatments for various diseases.
